Log In
BCIQ
Print this Print this
 

Equa, Galvus, Xiliarx, vildagliptin

Also known as: Jalra (formerly LAF237)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionDipeptidyl peptidase-4 (DPP-4) inhibitor
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase (DPP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes; Treat Type II diabetes in patients with moderate or severe renal impairment
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/09/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today